NUS Stock Overview
Engages in the development and distribution of various beauty and wellness products worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Nu Skin Enterprises, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$6.66 |
| 52 Week High | US$20.75 |
| 52 Week Low | US$5.95 |
| Beta | 1.18 |
| 1 Month Change | -7.76% |
| 3 Month Change | -2.77% |
| 1 Year Change | -65.35% |
| 3 Year Change | -86.96% |
| 5 Year Change | -83.75% |
| Change since IPO | -76.83% |
Recent News & Updates
Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns
Dec 21
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?
Nov 12Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nov 12Recent updates
Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns
Dec 21Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?
Nov 12Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nov 12The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%
Oct 04Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business
Aug 31Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price
Aug 13Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
May 13Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal
Mar 28Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty
Mar 04We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings
Feb 22Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06
Feb 19Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically
Feb 18Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks
Jan 18Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39
Nov 17Nu Skin: Is It Just A Growth Problem?
Oct 17Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Oct 09When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?
Sep 27Nu Skin: Attractive Valuation Trumps Near-Term Risks
Sep 12Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39
Aug 05Is Nu Skin Enterprises, Inc. (NYSE:NUS) Expensive For A Reason? A Look At Its Intrinsic Value
Jul 31Nu Skin: A High-Risk/High-Reward Turnaround Play Worth The Risks
Jun 26Is Now The Time To Look At Buying Nu Skin Enterprises, Inc. (NYSE:NUS)?
Jun 23We Think Nu Skin Enterprises (NYSE:NUS) Is Taking Some Risk With Its Debt
May 22Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.39
May 07Nu Skin Enterprises (NYSE:NUS) Could Be Struggling To Allocate Capital
Apr 26Why Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Worth Watching
Mar 18Nu Skin Enterprises (NYSE:NUS) Will Pay A Larger Dividend Than Last Year At $0.39
Feb 19Shareholder Returns
| NUS | US Personal Products | US Market | |
|---|---|---|---|
| 7D | -9.0% | -3.1% | -0.4% |
| 1Y | -65.3% | -24.7% | 24.8% |
Return vs Industry: NUS underperformed the US Personal Products industry which returned -24.7% over the past year.
Return vs Market: NUS underperformed the US Market which returned 23.9% over the past year.
Price Volatility
| NUS volatility | |
|---|---|
| NUS Average Weekly Movement | 6.9% |
| Personal Products Industry Average Movement | 8.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 17.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: NUS has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: NUS's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1984 | 3,700 | Ryan Napierski | www.nuskin.com |
Nu Skin Enterprises, Inc., together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products. The company also provides wellness products, such as LifePak nutritional supplements, ageLOC TR90 weight management system, and Beauty Focus Collagen+.
Nu Skin Enterprises, Inc. Fundamentals Summary
| NUS fundamental statistics | |
|---|---|
| Market cap | US$331.08m |
| Earnings (TTM) | -US$103.21m |
| Revenue (TTM) | US$1.78b |
0.2x
P/S Ratio-3.2x
P/E RatioIs NUS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NUS income statement (TTM) | |
|---|---|
| Revenue | US$1.78b |
| Cost of Revenue | US$454.34m |
| Gross Profit | US$1.32b |
| Other Expenses | US$1.42b |
| Earnings | -US$103.21m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -2.08 |
| Gross Margin | 74.41% |
| Net Profit Margin | -5.81% |
| Debt/Equity Ratio | 61.3% |
How did NUS perform over the long term?
See historical performance and comparisonDividends
3.6%
Current Dividend Yield-27%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 04:42 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Nu Skin Enterprises, Inc. is covered by 15 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anand Vankawala | Avondale Partners |
| Olivia Tong Cheang | BofA Global Research |
| April Scee | BTIG |